Mexico’s private health insurance market: Pressures and opportunities

Mexico is experiencing the same pressures seen in many other healthcare systems, but at a faster pace. There is a rapidly ageing population, the chronic disease burden is increasing, and obesity is adding to long-term morbidity, including at younger ages. Despite this, much of private healthcare utilization in Mexico still starts in secondary care rather than through strong primary care pathways. For insurers, that means fewer opportunities for preventative care, earlier diagnosis and proactive disease management. It also means that treatment often begins later, when conditions are more complex and more expensive to manage.

The dominant fee-for-service payment model between insurers and providers adds further structural pressure. Where providers are paid per consultation, test or procedure, volume can rise without a corresponding improvement in outcomes. In some cases in Mexico, self-pay packages for straightforward procedures are lower than the amount billed to insurers for insured patients. These misaligned incentives between providers and insurers ultimately lead to unnecessary costs and consequently onwards premium increases for customers.

Medical cost inflation in Mexico has been running at elevated levels for several years. For example, in Mexico this year, inflation is projected to be higher than 13% and this double-digit medical trend is anticipated to continue over the next 3-years. In addition, recent tax changes affecting the treatment of VAT on direct claim payments to third-party providers are leading to added upwards pressure on major medical insurance premiums. Businesses and insured households are already devoting a significant share of income to coverage, and these latest price increases will be hard for them to absorb. The immediate risks for insurers include downgrades, partial family lapses and anti-selection on renewal.

In many markets, including Mexico, insurers do not always own the customer relationship. Health insurance distribution in Mexico sits heavily with brokers (in the corporate segment) and agents (in the individual segment) and insurers lack not only the relationship with the customer but in some cases even their contact information. This makes direct engagement between insurers and customers challenging.

Intermediation is also a critical challenge from a product value perspective. When a significant proportion of premiums pay commissions, the remaining value available in the product is diminished. Whereas in other markets the individual segment is robust and growing, Mexican health insurers have struggled to develop direct-to-consumer channels.

Better data can improve almost every part of the value chain, from underwriting and product design to provider management, fraud detection and customer retention. Both customer and claims data is a challenge in Mexico. For example, inconsistent data such as non-standardized procedure coding, limited visibility at treating-doctor level and a lack of information on patient outcomes and experience. In the absence of granular claims data, it is more difficult to build predictive risk models and to identify avoidable costs such as fraud or over-utilization and to guide members to higher-value, more effective care.